Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ODTC | Odonate Therapeutics, Inc. | Chief Executive Officer, Director, 10%+ Owner | $20M | Nov 17, 2021 | ||
JNCE | Jounce Therapeutics, Inc. | Director, 10%+ Owner | $18.5K | May 3, 2023 | ||
RAIN | Rain Oncology Inc. | 10%+ Owner | $0 | +$69.6K | Jan 26, 2024 | |
TCRR | TCR2 THERAPEUTICS INC. | 10%+ Owner | $0 | Jun 1, 2023 | ||
APVO | Aptevo Therapeutics Inc. | Exit Filing | Nov 23, 2021 | |||
LJPC | LA JOLLA PHARMACEUTICAL CO | Director, 10%+ Owner | Aug 22, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|